Key facts
- Qure.ai’s last known valuation is $231.0M (Sep 2024).
- It has raised $156.5M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Peak XV Partners, General Atlantic, AI Venture Labs, Novo Holdings, MassMutual Ventures — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Qure.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Qure.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qure.ai
Developer of an automated interpretation technology designed to make healthcare affordable and accessible. The company's tech utilizes artificial intelligence and algorithms for classifying radiology images as normal or abnormal, diagnosing disease and highlighting abnormalities that may otherwise be overlooked, enabling doctors to diagnose diseases and highlight abnormalities more accurately.
- Sector
- Healthcare
- HQ
- Mumbai, India
- Founded
- 2016
- Employees
- 163
- Website
- qure.ai/
- Ownership
- Privately Held (backing)
Qure.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qure.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qure.ai in its N-PORT filings yet. We sweep new filings monthly.